New drug shows promise for lung cancer patients with brain tumors
NCT ID NCT05465343
First seen Nov 20, 2025 · Last updated May 15, 2026 · Updated 21 times
Summary
This study tested a drug called furmonertinib in 24 adults with advanced lung cancer (non-small cell) that has specific EGFR gene changes and has spread to the brain. The goal was to see if the drug can control brain tumors and delay their growth. Participants took the drug and were monitored for how long the brain tumors stayed stable or shrank.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NSCLC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ethics Committee
Beijing, 100021, China
Conditions
Explore the condition pages connected to this study.